Is It Feasible to Complete RCT for Intermediate Risk Studies in Europe and the US Lessons Form SURTAVI? - P. Serruys, MD, PhD

↳ This is a section part of Moment: CRT 2015 Valve & Structural - Percutaneous Aortic Valves: Regulatory Pathways in 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$5.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Is It Feasible to Complete RCT for Intermediate Risk Studies in Europe and the US Lessons Form SURTAVI? presented by P. Serruys, MD, PhD at CRT 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$5.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists 
  • Structural Heart Specialists 
  • Interventional Fellows 
  • Cardiac Surgeons

Session Name: Percutaneous Aortic Valves: Regulatory Pathways in 2015

Track: Valve & Structural

Learning Objectives

  • Update in advances/best practice in Valve & Structural procedures

Other Components in this Moment

Overview
What Regulatory Challenges Do the Next Wave of TAVR Devices Face in the U.S.? - Keith D. Dawkins, MD
Opportunities to Study Valve Iterations and Modifications for Approval in the U.S. - Rhonda J. Robb, MBA
Lessons Learned from TAVR Pivotal Trials in the U.S. - Michael J. Mack, MD
Is It Feasible to Complete RCT for Intermediate Risk Studies in Europe and the US Lessons Form SURTAVI? - P. Serruys, MD, PhD
Loading Simple Education